FDA ex­pands faster drug re­view pi­lot from sup­ple­men­tal to full ap­pli­ca­tions

The FDA on Dec. 2 will open up an ex­pe­dit­ed re­view pi­lot pro­gram that’s meant to speed ther­a­pies that sub­stan­tial­ly im­prove up­on what’s cur­rent­ly avail­able …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER